Pacific Biosciences
PACB
PACB
132 hedge funds and large institutions have $361M invested in Pacific Biosciences in 2020 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 52 increasing their positions, 43 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
37% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 30
39% less capital invested
Capital invested by funds: $592M → $361M (-$231M)
Holders
132
Holding in Top 10
2
Calls
$989K
Puts
$1.15M
Top Buyers
| 1 | +$16.8M | |
| 2 | +$16.7M | |
| 3 | +$12.7M | |
| 4 |
PC
Polar Capital
London,
United Kingdom
|
+$9.41M |
| 5 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$8.21M |
Top Sellers
| 1 | -$35.7M | |
| 2 | -$16.2M | |
| 3 | -$15.1M | |
| 4 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$5.05M |
| 5 |
Morgan Stanley
New York
|
-$4.44M |